Risk of Venous Thromboembolism in Patients With Cancer Treated With Cisplatin: A Systematic Review and Meta-Analysis
Seng S, Liu Z, Chiu S, Proverbs-Singh T, Sonpavde G, Choueiri T, Tsao C, Yu M, Hahn N, Oh W, Galsky M. Risk of Venous Thromboembolism in Patients With Cancer Treated With Cisplatin: A Systematic Review and Meta-Analysis. Journal Of Clinical Oncology 2012, 30: 4416-4426. PMID: 23150697, DOI: 10.1200/jco.2012.42.4358.Peer-Reviewed Original ResearchConceptsRisk of venous thromboembolic eventsCisplatin-based chemotherapyVenous thromboembolic eventsNon-cisplatin-based chemotherapySolid tumorsRandomized Controlled TrialsIncreased risk of VTENon-cisplatin-based regimensIncreased riskPatients treated with cisplatin-based chemotherapyIncidence of venous thromboembolic eventsIncreased risk of thromboembolismMeta-analysis of randomized controlled trialsRisk of venous thromboembolismControlled TrialsAdvanced solid tumorsMeta-analysisRisk of thromboembolismExploratory subgroup analysisRandom-effects modelCisplatin-basedCisplatin doseIII trialsThromboembolic eventsVenous thromboembolismArterial Thromboembolism in Cancer Patients Treated With Cisplatin: A Systematic Review and Meta-analysis
Proverbs-Singh T, Chiu S, Liu Z, Seng S, Sonpavde G, Choueiri T, Tsao C, Yu M, Hahn N, Oh W, Galsky M. Arterial Thromboembolism in Cancer Patients Treated With Cisplatin: A Systematic Review and Meta-analysis. Journal Of The National Cancer Institute 2012, 104: 1837-1840. PMID: 23093559, DOI: 10.1093/jnci/djs435.Peer-Reviewed Original ResearchConceptsArterial thromboembolic eventsIncreased risk of arterial thromboembolic eventsIncidence of arterial thromboembolic eventsNon-cisplatin-based chemotherapyPatients treated with cisplatin-based chemotherapyRisk of arterial thromboembolic eventsMeta-analysis of randomized controlled trialsCisplatin-based chemotherapyMeta-analysisConfidence intervalsRandom-effects modelCisplatin-basedRandomized Controlled TrialsIII trialsThromboembolic eventsRetrospective studySolid tumorsCase reportArterial thromboembolismCancer patientsIncreased riskControlled TrialsIncidence ratePatientsSystemic reviewRisk of venous thromboembolism in cancer patients treated with cisplatin: A systematic review and meta-analysis.
Seng S, Liu Z, Chiu S, Proverbs-Singh T, Sonpavde G, Choueiri T, Tsao C, Yu M, Hahn N, Oh W, Galsky M. Risk of venous thromboembolism in cancer patients treated with cisplatin: A systematic review and meta-analysis. Journal Of Clinical Oncology 2012, 30: e21016-e21016. DOI: 10.1200/jco.2012.30.15_suppl.e21016.Peer-Reviewed Original ResearchRisk of venous thromboembolic eventsCisplatin-based chemotherapyVenous thromboembolic eventsPatients treated with cisplatin-based chemotherapyRandomized Controlled TrialsAdvanced solid tumorsThromboembolic eventsSolid tumorsCisplatin doseMeta-analysisIncreased risk of VTESubgroup analysisConfidence intervalsNon-cisplatin-based chemotherapyIncreased riskIncidence of venous thromboembolic eventsCancer patients treated with cisplatinPatients treated with cisplatinIncreased risk of thromboembolismMeta-analysis of randomized controlled trialsRisk of venous thromboembolismNon-cisplatin chemotherapyRisk of thromboembolismTrial of patientsHigher relative risk
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply